| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/08/1999 | WO1999033963A1 Metastatic cancer regulated gene |
| 07/08/1999 | WO1999033873A1 NOVEL POLYPEPTIDES, cDNAS ENCODING THE SAME AND UTILIZATION THEREOF |
| 07/08/1999 | WO1999033870A2 Human regulatory proteins |
| 07/08/1999 | WO1999033869A2 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
| 07/08/1999 | WO1999033868A2 Human papillomavirus vaccine |
| 07/08/1999 | WO1999033859A2 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 07/08/1999 | WO1999033858A2 Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use |
| 07/08/1999 | WO1999033851A1 N-het-substituted glycerophosphoethanolamines |
| 07/08/1999 | WO1999033834A1 Novel farnesyl transferase inhibitors, preparation, pharmaceutical compositions containing them and use for preparing medicines |
| 07/08/1999 | WO1999033832A1 Cytotoxic alkaloid derivatives including asmarine a and b isolated from a sponge |
| 07/08/1999 | WO1999033829A1 Novel camptothecin tetracyclic analogues, preparation, methods, applications as medicines and pharmaceutical compositions containing them |
| 07/08/1999 | WO1999033824A1 Heterocyclic topoisomerase poisons |
| 07/08/1999 | WO1999033822A1 Indole derivatives useful a.o. for the treatment of osteoporosis |
| 07/08/1999 | WO1999033789A1 SUBSTITUTED β-ALANINES |
| 07/08/1999 | WO1999033782A1 Anticancer platinum (iv) complexes for oral administration |
| 07/08/1999 | WO1999033488A2 Adjuvanted vaccine formulation |
| 07/08/1999 | WO1999033485A1 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas |
| 07/08/1999 | WO1999033461A1 C-10 carbon-substituted artemisinin-like trioxane compounds having antimalarial, antiproliferative and antitumour activities |
| 07/08/1999 | WO1999033451A2 Mixture and pharmaceutical composition comprising z-4-hydroxytamoxifen and cyclodextrin |
| 07/08/1999 | WO1999024073B1 Pharmaceutical compositions containing cyclodextrins and taxoids |
| 07/08/1999 | WO1999019466A3 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities |
| 07/08/1999 | WO1999014231A3 Bifidus stimulating peptides and its uses |
| 07/08/1999 | WO1999004810A3 Use of mhc class ii ligands as adjuvant for vaccination and of lag-3 in cancer treatment |
| 07/08/1999 | WO1999004265A9 Cancer associated nucleic acids and polypeptides |
| 07/08/1999 | CA2317112A1 C-10 carbon-substituted artemisinin-like trioxane compounds having antimalarial, antiproliferative and antitumour activities |
| 07/08/1999 | CA2316397A1 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
| 07/08/1999 | CA2316308A1 Cytotoxic alkaloid derivatives including asmarine a and b isolated from a sponge |
| 07/08/1999 | CA2316235A1 Substituted .beta.-alanines |
| 07/08/1999 | CA2316221A1 Heterocyclic topoisomerase poisons |
| 07/08/1999 | CA2316079A1 Human regulatory proteins |
| 07/08/1999 | CA2315977A1 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas |
| 07/08/1999 | CA2315723A1 Indole derivatives useful a.o. for the treatment of osteoporosis |
| 07/08/1999 | CA2315617A1 Human signal peptide-containing proteins |
| 07/08/1999 | CA2315276A1 Human papillomavirus vaccine |
| 07/08/1999 | CA2315144A1 Novel farnesyl transferase inhibitors, preparation, pharmaceutical compositions containing them and use for preparing medicines |
| 07/07/1999 | EP0927758A2 Recombinant antibodies specific for TNF-Alpha |
| 07/07/1999 | EP0927555A1 Use of cyclooxygenase-2 inhibitors for the treatment and prevention of tumors, tumor-related disorders and cachexia |
| 07/07/1999 | EP0927257A2 Human protein kinases |
| 07/07/1999 | EP0927244A1 Semi-allogeneic cell hybrids as preventive and therapeutic vaccines for cancer and aids |
| 07/07/1999 | EP0927217A1 Angiogenic inhibitory compounds |
| 07/07/1999 | EP0927183A1 Spirocyclic metalloprotease inhibitors |
| 07/07/1999 | EP0927182A2 Alkylated rapamycin derivatives |
| 07/07/1999 | EP0927181A1 Tricyclic compounds useful as fpt inhibitors |
| 07/07/1999 | EP0927179A1 Substituted benzocycloheptapyridine derivatives useful for inhibition of farnesyl protein transferase |
| 07/07/1999 | EP0927178A1 Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 07/07/1999 | EP0927177A1 Novel benzothiophene derivatives, their preparation and use as urokinase inhibitors |
| 07/07/1999 | EP0927168A1 1,3-diheterocyclic metalloprotease inhibitors |
| 07/07/1999 | EP0927161A1 Substituted cyclic amine metalloprotease inhibitors |
| 07/07/1999 | EP0927156A1 Biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases |
| 07/07/1999 | EP0927150A1 Lipoxin compounds and their use in treating cell proliferative disorders |
| 07/07/1999 | EP0927046A1 Mammalian regulator of nonsense-mediated rna decay |
| 07/07/1999 | EP0927045A2 Tumor homing molecules, conjugates derived therefrom, and methods of using same |
| 07/07/1999 | EP0927043A1 Method for gene transfer to the central nervous system |
| 07/07/1999 | EP0927033A1 Retinoyloxy(substituted)alkylene butyrates useful for the treatment of cancer and other proliferative diseases |
| 07/07/1999 | EP0927030A1 Use of aryl n-substituted carboxamides to kill tumors |
| 07/07/1999 | EP0805807B1 2-(2-amino-3-methoxyphenyl)-4-oxo-4h-(1)benzopyran for treating proliferative disorders |
| 07/07/1999 | EP0637336B1 Mn gene and protein |
| 07/07/1999 | EP0609437B1 Novel sphingoglycolipid and use thereof |
| 07/07/1999 | CN1222193A Extracellular matrix signalling molecules |
| 07/07/1999 | CN1222144A Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents |
| 07/07/1999 | CN1221616A Prescription, preparation of medicine for treating cancer and its instructions of taking medicine |
| 07/07/1999 | CN1221614A Chinese medicine for preventing tumour and use in making drug |
| 07/07/1999 | CN1043997C 2,6-diaminopurine derivatives, its use and medicinal compsns. containing same |
| 07/06/1999 | US5919911 Monoclonal antibodies to stem cell factor receptors |
| 07/06/1999 | US5919829 Gastrin and cck receptor ligands |
| 07/06/1999 | US5919821 Plant extract |
| 07/06/1999 | US5919818 Tocotrienols and tocotrienol-like compounds and methods for their use |
| 07/06/1999 | US5919816 Administering drug with protective agent |
| 07/06/1999 | US5919815 Taxane compounds and compositions |
| 07/06/1999 | US5919807 Benzothiazoles and benzoxazoles, drugs containing them, their use and methods of preparing them |
| 07/06/1999 | US5919791 Ellipticine compounds |
| 07/06/1999 | US5919789 Xanthines and their therapeutic use |
| 07/06/1999 | US5919773 Antisense oligonucleotide modulation of raf gene expression |
| 07/06/1999 | US5919772 Oligonucleotide complementary to dna methyltransferase mrna. |
| 07/06/1999 | US5919759 Organ transplant; wound healing agents |
| 07/06/1999 | US5919687 Polynucleotide coding for neutral sphingomyelinase; for screening compounds for diagnosis and treatment of diseases; antiarthritic/antitumor/anticarcinogenic/anticholesterol agents; psychological/nervous system disorders |
| 07/06/1999 | US5919660 Human requiem |
| 07/06/1999 | US5919659 Polynucleotide |
| 07/06/1999 | US5919615 Polypeptides and antibodies characteristic of papillomavirus, and diagnostic procedures and vaccines making use of them |
| 07/06/1999 | US5919459 Compositions and methods for treating cancer and hyperproliferative disorders |
| 07/06/1999 | US5919456 IL-13 receptor specific chimeric proteins |
| 07/06/1999 | US5919455 Non-antigenic branched polymer conjugates |
| 07/06/1999 | US5919450 Glutathione S-transferase homolog |
| 07/06/1999 | CA1340631C N- (5,6,7,8-tetrahydropyrido [2,3-d] pyrimidin-6-yl-alkanoyl)-glutamic acid derivatives |
| 07/01/1999 | WO1999032648A1 Recombinant rhabdovirus containing a heterologous fusion protein |
| 07/01/1999 | WO1999032644A2 Prostate cancer gene |
| 07/01/1999 | WO1999032637A1 Human signal transduction serine/threonine kinase |
| 07/01/1999 | WO1999032625A2 Nucleotide and protein sequence of mammastatin and methods of use |
| 07/01/1999 | WO1999032620A1 Insulin-like growth factor binding protein fragments and the utilization thereof |
| 07/01/1999 | WO1999032614A1 Secreted proteins and polynucleotides encoding them |
| 07/01/1999 | WO1999032610A1 Human nucleotide pyrophosphohydrolase-2 |
| 07/01/1999 | WO1999032516A2 Pharmaceutical compositions containing the long pentraxin ptx3 |
| 07/01/1999 | WO1999032514A2 Sag: sensitive to apoptosis gene |
| 07/01/1999 | WO1999032509A2 Hemiasterlin analogs |
| 07/01/1999 | WO1999032491A1 Novel acronycine derivatives, preparation method and pharmaceutical compositions |
| 07/01/1999 | WO1999032483A1 New pharmaceutically active compounds |
| 07/01/1999 | WO1999032455A1 Inhibition of raf kinase using aryl and heteroaryl substituted heterocyclic ureas |
| 07/01/1999 | WO1999032452A1 Carboxyl acid substituted heterocycles as metalloproteinase inhibitors |
| 07/01/1999 | WO1999032451A1 Azepine or larger medium ring derivatives and their use as pharmaceuticals |
| 07/01/1999 | WO1999032448A1 Substituted pyridine and pyridazine compounds and their pharmaceutical use |